Osaic Holdings
TBPH icon

Osaic Holdings’s Theravance Biopharma TBPH Stock Holding History

Osaic Holdings’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Sell
1,632
-14
-0.9% -$232 ﹤0.01% 5908
2026
Q1 		$26.7K Sell
1,646
-37
-2% -$655 ﹤0.01% 5667
2025
Q4 		$31.5K Sell
1,683
-79
-4% -$1.31K ﹤0.01% 5555
2025
Q3 		$25.7K Buy
1,762
+73
+4% +$922 ﹤0.01% 5768
2025
Q2 		$18.6K Buy
1,689
+1,561
+1,220% +$15.2K ﹤0.01% 5772
2025
Q1 		$1.14K Sell
128
-1,256
-91% -$11.7K ﹤0.01% 6780
2024
Q4 		$13K Buy
1,384
+1,340
+3,045% +$12.2K ﹤0.01% 5615
2024
Q3 		$355 Sell
44
-188
-81% -$1.63K ﹤0.01% 7074
2024
Q2 		$1.97K Buy
232
+94
+68% +$848 ﹤0.01% 6600
2024
Q1 		$1.24K Hold
138
– – ﹤0.01% 6627
2023
Q4 		$1.55K Hold
138
– – ﹤0.01% 6622
2023
Q3 		$1.19K Hold
138
– – ﹤0.01% 6780
2023
Q2 		$1.43K Hold
138
– – ﹤0.01% 6772
2023
Q1 		$1.5K Hold
138
– – ﹤0.01% 6828
2022
Q4 		$2K Hold
138
– – ﹤0.01% 6713
2022
Q3 		$1K Hold
138
– – ﹤0.01% 7068
2022
Q2 		$1K Hold
138
– – ﹤0.01% 7152
2022
Q1 		$1K Hold
138
– – ﹤0.01% 7119
2021
Q4 		$2K Hold
138
– – ﹤0.01% 7054
2021
Q3 		$1K Hold
138
– – ﹤0.01% 7079
2021
Q2 		$2K Hold
138
– – ﹤0.01% 6749
2021
Q1 		$3K Sell
138
-78
-36% -$1.48K ﹤0.01% 6399
2020
Q4 		$4K Hold
216
– – ﹤0.01% 5885
2020
Q3 		$3K Sell
216
-10
-4% -$187 ﹤0.01% 5757
2020
Q2 		$5K Hold
226
– – ﹤0.01% 5493
2020
Q1 		$5K Buy
+226
New +$5.66K ﹤0.01% 5358

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Osaic Holdings's TBPH Position: Q2 2026 in Review

Osaic Holdings reduced its Theravance Biopharma (TBPH) stake by 0.85% in Q2 2026, selling an estimated $232 and leaving 1,632 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5908.

Osaic Holdings first reported a position in TBPH in Q1 2020 and has held it in 26 quarters since. The position peaked at $31.5K in Q4 2025. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Osaic Holdings held 1,632 shares of Theravance Biopharma worth $27.7K as of Q2 2026.
  • Osaic Holdings sold 14 Theravance Biopharma shares in Q2 2026, an estimated $232.
  • Theravance Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5908 holding.
  • Osaic Holdings first reported a position in Theravance Biopharma in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Theravance Biopharma position peaked at $31.5K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.